Literature DB >> 10081682

Proficiency of clinical laboratories in and near Monterrey, Mexico, to detect vancomycin-resistant enterococci.

L C McDonald1, L R Garza, W R Jarvis.   

Abstract

Early detection of vancomycin-resistant enterococci is important for preventing its spread among hospitalized patients. We surveyed the ability of eight hospital laboratories in and near Monterrey, Mexico, to detect vancomycin resistance in Enterococcus spp. and found that although laboratories can reliably detect high-level vancomycin resistance, many have difficulty detecting low-level resistance.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10081682      PMCID： PMC2627684          DOI： 10.3201/eid0501.990117

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN： 1080-6040            Impact factor:   6.883


  8 in total

1.  Are clinical laboratories in California accurately reporting vancomycin-resistant enterococci?

Authors:  J Rosenberg; F C Tenover; J Wong; W Jarvis; D J Vugia
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

2.  Ability of commercial and reference antimicrobial susceptibility testing methods to detect vancomycin resistance in enterococci.

Authors:  F C Tenover; J M Swenson; C M O'Hara; S A Stocker
Journal:  J Clin Microbiol       Date:  1995-06       Impact factor: 5.948

3.  Study to determine the ability of clinical laboratories to detect antimicrobial-resistant Enterococcus spp. in Buenos Aires, Argentina.

Authors:  S T Cookson; H Lopardo; M Marin; R Arduino; M J Rial; M Altschuler; L Galanternik; J M Swenson; J I Tokars; W R Jarvis
Journal:  Diagn Microbiol Infect Dis       Date:  1997-10       Impact factor: 2.803

4.  Revised approach for identification and detection of ampicillin and vancomycin resistance in Enterococcus species by using MicroScan panels.

Authors:  P C Iwen; D M Kelly; J Linder; S H Hinrichs
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

5.  Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States.

Authors:  T M Coque; J F Tomayko; S C Ricke; P C Okhyusen; B E Murray
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

6.  New vancomycin disk diffusion breakpoints for enterococci. The National Committee for Clinical Laboratory Standards Working Group on Enterococci.

Authors:  J M Swenson; M J Ferraro; D F Sahm; P Charache; F C Tenover
Journal:  J Clin Microbiol       Date:  1992-10       Impact factor: 5.948

7.  Ability of clinical laboratories to detect antimicrobial agent-resistant enterococci.

Authors:  F C Tenover; J Tokars; J Swenson; S Paul; K Spitalny; W Jarvis
Journal:  J Clin Microbiol       Date:  1993-07       Impact factor: 5.948

8.  Screening of stool samples for identification of vancomycin-resistant Enterococcus isolates should include the methyl-alpha-D-glucopyranoside test to differentiate nonmotile Enterococcus gallinarum from E. faecium.

Authors:  C Y Turenne; D J Hoban; J A Karlowsky; G G Zhanel; A M Kabani
Journal:  J Clin Microbiol       Date:  1998-08       Impact factor: 5.948
  8 in total
  2 in total

1.  Proficiency in detecting vancomycin resistance in enterococci among clinical laboratories in Santiago, Chile.

Authors:  J A Labarca; L C McDonald; M E Pinto; E Palavecino; P González; E Cona; A Fernández; M S Giglio; W R Jarvis
Journal:  Emerg Infect Dis       Date:  1999 Nov-Dec       Impact factor: 6.883

2.  Vancomycin-resistant enterococci, Mexico City.

Authors:  Jennifer Cuellar-Rodríguez; Arturo Galindo-Fraga; Víctor Guevara; Carolina Pérez-Jiménez; Luis Espinosa-Aguilar; Ana Lilia Rolón; Araceli Hernández-Cruz; Esaú López-Jácome; Miriam Bobadilla-del-Valle; Areli Martínez-Gamboa; Alfredo Ponce-de-León; José Sifuentes-Osornio
Journal:  Emerg Infect Dis       Date:  2007-05       Impact factor: 6.883
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.